Trending News
News
News
Nearly 50% of Blood Cancer Patients Insufficiently Protected Against Omicron
According to new data from the Francis Crick Institute and The Royal Marsden NHS Foundation Trust, nearly fifty percent of blood cancer patients do not have enough antibodies able to neutralize Omicron after a third vaccine dose.
News
Convalescent Plasma Could Be Beneficial for Subgroups of Patients With COVID-19
A study has shown that transfusions of blood plasma donated by people who have already recovered from COVID-19 infection may help other hospitalized patients.
News
Plant Defense "Shields" Overcome When Viral Proteins Join Forces
New research into how viral proteins interact and can be disabled holds promise to help plants defend themselves against viruses—and ultimately prevent crop losses.
News
A New Way To Attack Herpesviruses
A study has identified a new approach to attacking herpesviruses.
News
Novel Avian Immunological Pathway Uncovered
A new immune pathway has been discovered in chickens that viruses — such as those that tend to infect birds, humans and animals and spread diseases like influenza or Crimean-Congo hemorrhagic fever — may be targeting.
News
Overweight Dogs Benefit From a High-Protein, High-Fiber Diet
Overweight dogs fed a high-protein and high-fiber diet showed positive changes in body composition and inflammatory markers alongside weight loss.
News
Four COVID-19 Vaccines Teach T Cells To Fight SARS-CoV-2
Scientists have found that four COVID-19 vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2. These T cells can recognize SARS-CoV-2 Variants of Concern, including Delta and Omicron.
News
Understanding What Impacts Gut Microbiota Transplantation Success
Scientists have explored the effect of donor selection on the establishment and long-term stability of transplanted microbiota, especially in aged hosts.
News
Why Does Omicron Cause Less Severe Disease Than Other Variants?
Replication of the omicron variant of SARS-CoV-2 within cells is drastically lower than previous variants, perhaps as a result of the virus mutating to escape the immune response.
News
Peptide-Enhanced Anticancer Drug Targets Bone Metastasis
An affinity peptide for the bone cancer niche has been attached to a breast cancer drug, and the combined therapy has shown promise for cancer treatment in rodent models.
Advertisement